Jeffrey K. Belk
John D. Doyle
David Gruber MD, MBA
Ilene J. Klein, MD, FAAFP
Thomas G. Klopack
Rajiv Kumar, MD
David Medvedeff, PharmD
Byron Osing, PhD
Matt Patterson, MD
R. Jamie Spriggs
Steven R. Steinhubl, MD
Chief Strategy Officer, Velocity Growth
Founder, Comunicano, Inc.Andy Abramson is the founder of Comunicano, Inc., a full-service value creation communications agency, servicing start-ups, companies in transition and established brands with regard to marketing, advertising, public relations, promotion, events and reputation management. Founded in 1992, Comunicano operates globally as a virtual company, since 2000 the company has participated in the 33 company exits in the mobile, telecom or IT infrastructure sectors. Andy started his career in the marketing department of a professional sports team at age 14 and has been at it ever since. He has held a series of marketing and communications managerial roles with three professional sports teams – Philadelphia Wings, Philadelphia Flyers and Denver Nuggets, with roles in senior account management within the Foote, Cone and Belding/Impact and guiding the public relations and sports marketing for The Upper Deck Company, before founding Comunicano in 1992. Often quoted in the consumer and technology press, since 2003 Andy has authored VoIPWatch (http://www.andyabramson.com), a leading industry blog focused on mobile, video, voice, collaboration, and OTT technology. He is also heard on the syndicated radio program, Business Rockstars, while also serving as a member of the board of advisors of multiple startups around the world.
Jeffrey K. Belk
Founder, Bright Light Management
Venture Partner, OurCrowd
Managing Director, ICT168 Capital LLC
Jeffrey Belk is Managing Director of ICT168 Capital, LLC, focused on developing and guiding global growth opportunities in the ICT (Information and Communication Technology space). Formerly, Belk spent almost 14 years at Qualcomm, where prior to his departure in early 2008, he was Qualcomm’s senior vice president of strategy and market development, focused on examining changes in the wireless ecosystem and formulating approaches to help accelerate mobile broadband adoption and growth. From 2000 until 2006, Belk was senior vice president, global marketing, leading a team responsible of all facets of the company’s corporate messaging, communications, and marketing worldwide. In 1999-2000, Belk was SVP & GM of Qualcomm Eudora Products, Qualcomm’s award winning email client. In 1997, Belk was named VP, marketing of Qualcomm Consumer Products, and initiated the company’s global branding and communications efforts. Prior to Qualcomm, Belk spent ten years in the early growth years of the PC industry, primarily with Proxima Corporation. Belk is on the Board of Directors of Peregrine Semiconductors, InterDigital Corporation, as well as the Board of the Wireless Life Sciences Alliance. He has a B.A. in Economics from University of California, San Diego, and an M.B.A. from the University of California, Irvine.
CEO & Co-Founder
Christian is a serial entrepreneur with a passion for supporting non-profit organizations. He has a diverse background in the financial, high-tech, and creative, industries. In 2006, he founded a WiFi company that later merged with OpenEye, a leading digital out of home media agency, where he continued to serve as Managing Partner until 2013, when he co-founded Benefunder. Prior to his first startup, Christian was a wealth advisor with Morgan Stanley and then Merrill Lynch. Throughout his career, he has always had a second ‘job’ volunteering in non-profit. Christian served as President of the Swedish American Chamber of Commerce when they hosted the largest business networking event between the two countries to date. He also co-founded Hunger at Home, a fundraiser for local homeless charities that partnered with Hilton Hotels for an innovative ‘zero overhead’ concept. Christian currently volunteers as a business advisor in the Connect Springboard program for entrepreneurs. Originally from Denmark, Christian returned to Southern California after completing his business degree and military service as sergeant/section commander in the 1st light infantry division. While serving, Christian was elected vice national spokesman for enlisted personnel. Christian currently resides in San Diego, CA with his wife and son.
John D. Doyle
Executive Vice President, Ascension
President and Chief Executive Officer, Ascension Holdings
John D. Doyle serves as Executive Vice President, Ascension, the parent organization of Ascension Health. He is also President and Chief Executive Officer, Ascension Holdings, a subsidiary of Ascension. Ascension Holdings is composed of a portfolio of companies designed to add value to the organization by providing services to the Health Ministries of Ascension Health as well as other health systems in the United States and internationally. Mr. Doyle, along with other executives, oversees incubation of transformational solutions and innovative relationships that have the potential to accelerate accomplishment of Ascension Health’s Strategic Direction. He also serves as Chairman of the Board of TriMedx, a subsidiary of Ascension Holdings that provides clinical engineering services to healthcare organizations throughout the United States and internationally. He serves on the Board of TriMedx International, a joint venture currently providing clinical engineering services in India. Before joining Ascension Health’s System Office, Mr. Doyle was Executive Vice President for Strategic Development for St. Vincent Hospitals and Health Services (now St.Vincent Health), overseeing strategic planning, network development, managed care, marketing, corporate communications and government affairs. Mr. Doyle earned a bachelor’s degree from Butler University, Indianapolis, and a master’s degree from Ball State University, Muncie, Ind.
President & CEO
Terry Edwards is the founding CEO and visionary behind PerfectServe, Inc., whose clinical communications platform is used by leading U.S. health systems to improve patient outcomes and operational efficiency. Some of PerfectServe’s clients include Advocate Healthcare, the MemorialCare Health System, St. Joseph Health, Spectrum Health and others. Starting in 1997, Edwards invented and began developing PerfectServe’s initial version one applications. Since that time he has successfully guided the company’s national expansion to more than 35,000 physician users while attracting more than $30 million in venture capital to fuel PerfectServe’s growth. Prior to PerfectServe, Edwards was introduced to technology-enabled services at Voice-Tel, Inc., a pioneer in the interactive voice messaging industry. Before that, he co-founded Milepost Corporation, a leading marketing communications firm that served a variety of Midwest-based Fortune 500 companies.
Greg possesses a comprehensive entrepreneurial and executive background in media and technology. Most recently, he served as Partner at Noro Moseley Partners, an Atlanta-‐based venture capital firm, with a concentration on early stage digital media companies. He has been a member of the management teams of three successful start ups: at iXL, he served as VP and General Manager of the Madrid, Spain office and Senior VP of Corporate Development for the Atlanta office. At Silverpop Systems, Greg was VP of Business and Corporate Development. Prior to SilverPop, he launched Southern Direct, where he served as CEO. Greg then joined Turner Broadcasting following Turner’s acquisition of Southern Direct, where he served as VP of Corporate Development, overseeing M&A and investment opportunities for all of Turner’s brands. He currently sits on the Board of Directors for The Onion, StatSheet, and PlayOn Sports and serves on the advisory board of Vertical Acuity, SolidFire and Clearleap. Greg holds a Bachelor’s degree in Mechanical Engineering, Magna Cum Laude, from Georgia Tech and an MBA from Harvard Business School. He is a member of the board of trustees for the Georgia Tech Alumni Association, the Georgia Council on Economic Education and the Bobby Dodd Foundation.
Kim Goodsell is a former world-ranked endurance athlete and UCSD dropout who continued her biological behavior studies in-vivo. Her body became her laboratory and remote environments became her lab. Today Kim is a digital patient, personal molecular researcher, activist in the ‘digital patient revolution,’ and co-founder of ProAbility WalKArt, a social entrepreneurship dedicated to the design of connected ‘Pedestrian Assistive Technology’ that enables people from all walks of life to walk. She co-invented ROVA, a mobility platform driving positive health outcomes by connecting its user to the fundamental function of walking and their realtime life data through their wireless “innernet.” Recognized by Eric Topol as “the patient of the future,” Topol invited Kim to tell her story of how she anticipated a novel genotype/phenotype correlation, self-financed genetic sequencing of the suspected culprit and discovered the unifying genetic substrate of her disease continuum. Co-author of her own case report, Kim’s abstract has been accepted by HRS for presentation at the 2014 HRS Annual Session. No stranger to the world of wireless medical sensors, Kim was implanted with life-saving digital technology in 1997. Practicing the art of risk management, Kim delicately balances the threat of sudden cardiac death and neurodegeneration with rigorous activity. The management of her arrhythmia is further aided by an AliveCor wireless heart monitor that gives her realtime EKG readout allowing her to triage her arrhythmia. She is passionate about patient’s rights to their vital health data.
David Gruber MD, MBA
Managing Director, Director of Research
Alvarez and Marsal
David Gruber MD, MBA is Managing Director and Director of Research with Alvarez and Marsal. He responsible for thought leadership, advanced analytics, and client consulting activities. Dr. Gruber brings 30 years of healthcare experience as a consultant, corporate executive and Wall Street analyst. Before joining A&M, he spent three years as the Founder of Healthcare Convergence Associates, a consulting firm focused on healthcare, technology and the consumer. Until 2008, Dr. Gruber was VP, Corporate Development and New Ventures with the J&J Consumer Group. In 1995-2004, he worked as a top-ten rated medical supplies and devices analyst at Lehman, Piper and Sanford Bernstein; and was the lead analyst for the IPO of Intuitive Surgical and Given Imaging, and a merchant banking investment in Therasense. Prior to Wall Street, Dr. Gruber was VP, Planning and Business Development for the $1.6 billion healthcare group at Bristol-Myers, inclusive of Zimmer and ConvaTec. Dr. Gruber is a magna cum laude graduate of a six-year BS-MD program at CCNY and the Mt. Sinai School of Medicine. He has an MBA from Columbia, and was a Kellogg Foundation National Fellow. He is currently a Senior Fellow, Healthcare Innovation and Technology Lab (HITLAB) at Columbia Presbyterian.
Senior Director Marketing, Research & Executive Programs
Chris joined TripleTree in August 2005 with over two decades of experience as an operating experience, analyst and entrepreneur in the technology industry. He leverages this experience at TripleTree in his role as Senior Director overseeing research, as well as leading the firm’s marketing and executive programs. Chris joined TripleTree from Tier1 Research, an independent sell side research firm where he was president and chief operating officer. Tier1 grew quickly as a result of the Wall Street global research settlement, and Chris successfully oversaw this growth as the firm was acquired in June 2005 by The 451 Group. Prior to Tier1 Research, Chris held executive positions at Gartner, GE Capital Consulting, IBM Global Services and a consulting firm which he founded. Chris is a frequent presenter at industry events and has been quoted in numerous trade and industry publications including the Wall Street Journal, the New York Times and CNN Money. Chris earned a BBA in Marketing from the University of Minnesota-Duluth, has completed advanced studies through the University of Minnesota and Michigan State University and is an active volunteer with his local youth athletic association.
Leroy Hood, MD, PhD
President and Co-founder
Institute for Systems Biology
The outstanding contributions of Dr. Hood have had a resounding effect on the advancement of science since the 1960s. Dr. Hood was involved in the development of five instruments critical for contemporary biology—namely, automated DNA sequencers, DNA synthesizers, protein sequencers, peptide synthesizers, and an ink jet printer for constructing DNA arrays. These instruments opened the door to high throughput biological data and the era of big data in biology and medicine. He helped pioneer the human genome program—making it possible with the automated DNA sequencer. Hood is now pioneering new approaches to P4 medicine—predictive, preventive, personalized and participatory, and most recently, has embarked on creating a P4 pilot project on 100,000 well individuals, that is transforming healthcare. In addition to his ground-breaking research, Dr. Hood has published 750 papers, received 36 patents, 17 honorary degrees and over 100 awards and honors. He is one of only 15 individuals elected to all three National Academies—the National Academy of Science, the National Academy of Engineering, and the Institute of Medicine. Dr. Hood has founded or co-founded 15 different biotechnology companies including Amgen, Applied Biosystems, Rosetta, Darwin, Integrated Diagnostics and Indi Molecular.
Dave Icke joined MC10 as CEO in March 2009. Dave built his career growing and scaling businesses that solve customer problems with breakthrough technology. Dave understands semiconductor manufacturing, starting as a process engineer at Cypress Semiconductor, then helping chipmakers worldwide quickly ramp their fabs in different leadership roles over 11 years at KLA-Tencor. He then led and grew several businesses in semiconductor test equipment at Teradyne. In 2005, he took the plunge into the startup world with Advanced Electron Beams, a venture-backed cleantech company with a disruptive platform technology serving multiple markets. MC10 offers a unique opportunity to combine Dave’s experiences in semiconductor manufacturing with breakthrough platform technology. Dave has a B.S. degree in Chemical Engineering from Stanford University, and an M.B.A. degree from Harvard Business School.
President & CEO
David is currently President and CEO of GreatCall Inc. GreatCall provides a wide range of mobile health and safety services to older consumers. Since the launch of the Jitterbug platform in 2006, GreatCall has been innovating in services ranging from mobile access to live registered nurses, medication adherence and wellness coaching to mobile personal emergency response. GreatCall’s services are available on proprietary devices designed for simplicity as well as on iOS and Android platforms. A leader in innovation, GreatCall’s “Jitterbug” was the first mobile service designed for older consumers and “5star Urgent Response” was one of the first mobile PERS solutions in the world. Before joining GreatCall, David was Vice President, Consumer Markets for Bell Mobility in Canada where he ran the $1.6 billion consumer market P&L. He was also Vice President, Consumer Marketing for Bell Canada where he ran the $4 billion wireline P&L. David was a Partner at DiamondCluster International in the Chicago and San Francisco offices. David holds a B.Sc. in Electrical Engineering from the University of Western Ontario. He has an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University and is also a licensed member of the Association of Professional Engineers.
Jeremy Jauncey is a consumer web and digital loyalty entrepreneur and Co-Founder of Tictrac. Based in London and New York, Tictrac is a lifestyle design platform that empowers people through their own data. Winner of ‘Best New Company’ at the internationally recognized Health 2.0 Conference (San Francisco, October 2012), Tictrac has been recognized by numerous publications as being the cutting edge of innovation in the field of personal tracking, lifestyle design and health & wellbeing. Prior to Tictrac, Jeremy was the Managing Director of Next Jump Ltd, a digital rewards and loyalty business from the U.S. that he set up in the U.K. The business provided employee and consumer engagement programs to over 70% of the Fortune 1000, online advertising solutions for 30,000 global merchants and covered 100 million users across the world. Jeremy is also on the Advisory Boards of: One Hundred Years, an innovative financial services and health management organization focused on international medical excellence and human longevity; The Nth Degree Club, a private dining and networking society; and, The Entrepreneurs Organization, voted by Forbes as the best entrepreneurs’ network in the world. Jeremy has a passion for professional sport, particularly the application of technology in elite performance/training environments and played rugby for Scotland whilst at school.
Chief Digital Officer
Scripps Translational Science Institute
Donald Jones is the Chief Digital Officer of the Scripps Translational Science Institute in La Jolla, California, where he works with the Director, Eric Topol, MD and Steve Steinhubl, MD, Director Scripps Digital Medicine, one of the first clinical trial centers focused exclusively on digital health and medicine products. Through February 2014, Mr. Jones served as Qualcomm Vice President of Wireless Health Global Strategy and Market Development. Mr. Jones is globally recognized as a leader in the field. In 2011, working with XPrize Foundation CEO, Peter Diamandis, and Qualcomm’s CEO, Dr. Paul Jacobs, he conceived the $10M Qualcomm Tricorder Xprize for a consumer device capable of making multiple diagnosis. In 2005, he founded and is Chairman of the Wireless Life Sciences Alliance (www.wirelesslifesciences.org). Mr. Jones is widely asked to speak and recent engagements have included the Milken Institute, Sanofi Executive Committee, J&J Innovations Master Class, MIT Emtech, the MEMS Industry Group, the NIH Directors Leadership Meeting, and the world’s largest trade show, CES. He is a member of the Milken Institute Advisory Committee on Biomedical Innovation. Jones holds a bachelors’ degree in biology and bioengineering from the University of California, San Diego, a Juris Doctor from the University of San Diego and an MBA from the University of California, Irvine.
Scott Jordan is an accomplished life sciences business development and investment banking professional with over 25 years of corporate experience in negotiating strategic corporate alliances, securing international licensing agreements, building national sales teams, and contributing to successful product development, approval, and launch. Scott is the Founder of HealthiosXchange, the leading healthcare Crowdfunding portal. Previously, Scott held business development and commercialization roles with Neopharm, Akorn Opthalmics, and Abbott Laboratories. Scott Graduated from the Kellstadt Graduate School of Business (MBA) and received a BA from Michigan State University. Scot is a Level II Candidate in the Chartered Financial Analyst (CFA) Program and holds Series 7, 66, 63 & 31 security licenses.
Ilene J. Klein, MD, FAAFP
Director of Global Employee Health Services
Dr. Ilene Klein is Qualcomm’s Director of Global Employee Health Services where she leads Qualcomm’s corporate strategy for health and wellness, including the expansion of onsite clinical services and the innovative use of Qualcomm enabled wireless technology to improve employee health. Ilene also serves as the Chair of the Qualcomm Life Advisory Council. Under her leadership as the first medical director for Qualcomm’s on-site employee health center, the health center grew to touch the lives of 1 out of every 3 San Diego employees. Prior to becoming a physician, Dr .Klein worked for many years as a public health care administrator most notably working to create a city-wide network of pediatric primary care medical homes, including medical homes for children with asthma for New York City’s Bureau of Child Health. Ilene holds undergraduate and graduate degrees in Music Therapy from New York University and earned her medical degree from Harvard Medical School. She is a board certified Family Physician and a Fellow of the American Academy of Family Physicians.
Thomas G. Klopack
Skylight Healthcare Systems
Thomas G. Klopack joined Skylight as chief executive office in July 2011. Klopack brings more than 35 years of experience in both strategic and operational roles for leading-edge, rapid-growth technology companies. Prior to joining Skylight, Klopack served as the CEO of Automedics, a medical device startup focused on improved IV drug delivery. He was president and CEO of IntelliDOT Corporation, a startup in hospital point-of-care medication delivery information systems before moving to Automedics. Klopack also served as CEO for Mountain View, Calif. – based Aclara Biosciences. Prior to Aclara, he was also executive director for Photothera after serving as chief operation officer for Aurora Biosciences Corporation. Before joining Aurora Biosciences, Klopack held multiple management positions at Raychem, part of Tyco Electronics and Tyco International. Klopack received a bachelor’s degree in chemical engineering from Carnegie Mellon University and earned a master’s of business administration from Harvard Business School.
Rajiv Kumar, MD
Founder and CEO
Dr. Rajiv Kumar is the founder and chief executive officer of ShapeUp, a venture-backed company that delivers social networking and gaming-based wellness programs to large employers and insurance companies. Under his leadership, ShapeUp now engages over one million participants across 128 countries. Dr. Kumar earned his medical degree from the Warren Alpert Medical School of Brown University and has focused his career on prevention, public health, and innovation in health care. He also received his Bachelor of Arts in Business Economics from Brown University.
James R. Mault, MD, F.A.C.S.
Vice President and Chief Medical Officer
James R. Mault, MD, F.A.C.S., is the vice president and chief medical officer of Qualcomm Life as a result of their April 2013 acquisition of HealthyCircles, a care coordination and remote patient monitoring software platform company founded and led by Dr. Mault since 2009. Prior to starting HealthyCircles, Dr. Mault was the director of new products and business development for the Health Solutions Group at Microsoft. Dr. Mault has more than 30 years of experience in senior executive positions in the Health IT and Medical Device industry as well as clinical medicine. Dr. Mault has founded five Health IT and medical device companies, leading these companies to develop novel devices and software technologies, FDA approvals, and strategic partnerships with numerous Fortune 500 companies. He is the named inventor of over 80 issued and pending U.S. Patents for a variety of novel health information and medical device innovations. He has been board-certified in both general surgery and cardiothoracic surgery, having specialized in heart and lung transplantation, thoracic oncology and critical care. He has conducted academic medical research under numerous grant awards from the National Institutes of Health, American Cancer Society, and others. He is the author of more than 60 scientific articles, chapters and books in the published medical literature. Dr. Mault holds a bachelor’s degree in Biology and a Medical Degree from the University of Michigan, and conducted his general surgery and cardiothoracic surgery residency training at Duke University Medical Center.
Anna McCollister-Slipp is co-founder of Galileo Analytics, a Visual Data Exploration and advanced data analytics company focused on democratizing access to and understanding of complex health data. Anna’s passion for innovation in health data analytics is rooted in her personal experiences living with type 1 diabetes. In her professional and personal activities, Anna seeks to build platforms for better understanding of and engagement with the needs of patients. She speaks frequently about the need for innovation in medical device data and technology, promoting data standards, device interoperability and user platforms aimed at empowering patients to better manage their health. As a health IT entrepreneur and patient advocate, Anna has been appointed to and served on a number of government and private committees and boards aimed at promoting innovative ways to better understand, manage and treat complex chronic health conditions, such as diabetes. She was a member of the ONC HIT Policy Committee’s FDASIA Workgroup, charged with advising the government on a regulatory pathway for HIT that would protect patients and promote innovation. Anna’s work as an advocate and entrepreneur has been featured in an array of publications and online media. She was named by XX In Health as a “Woman to Watch” at Health Datapalooza 2013, and as co-founder of Galileo Analytics, was one of a select group of innovators invited to participate in “The Hive” at TEDMED 2013.
David Medvedeff, PharmD
Dr. David Medvedeff is the CEO of VUCA Health; a company that directly addresses health literacy and serves as a gateway to patient engagement by leveraging mobile and web video technologies. David most recently served as the CEO of Avatar International, where he worked with prestigious organizations to give their patients a voice in the optimization of the care experience. His leadership and focus on organizational culture was instrumental in attracting top talent and ultimately delivering remarkable corporate results. Prior to joining Avatar International David was the President of Informed Decisions which was acquired by Elsevier Health. His multifaceted role with Elsevier included leading the company’s electronic prescribing initiatives, managing the predictive modeling and analytics unit, and serving as the VP of payer and provider strategy. David has been the humble recipient of numerous industry accolades. He has chaired the National Changing Diabetes Program Health Information Technology group and The PQA’s Diabetes and Medication Reconciliation Workgroups. He currently serves on the Board of Strata Decision Technology, Pharmacy Quality Solutions and the Executive Board of The Beryl Institute. Dr. Medvedeff earned his Doctor of Pharmacy and Master of Business Administration from the University of Florida.
Co-Founder, Director and CEO
Critical Alert Systems
Ed brings a proven track record of leadership and business building in the telecommunications and healthcare industries to Critical Alert. Following several successful years as an investment banker on Wall Street, he joined Talk America, Inc., a publicly-traded phone and data service provider. Ed became CEO of Talk America and during his 10-year tenure the company set industry records for customer service, besting companies such as AT&T to win a JD Powers and Associates award. Ed then served for two years as CEO of Cavalier Telephone & TV which sold voice, data, networking and fiber connectivity services to large enterprise customers including healthcare clients. In 2010, Ed co-founded Critical Alert Systems and has been responsible for developing and executing the company’s growth strategy in healthcare communications. He has spearheaded acquisitions and partnerships that have put Critical Alert at the forefront of integrated, innovative products and services in nurse call, mHealth and critical messaging. Ed also serves as Chairman of the Board of Extreme Networks (NASDAQ: EXTR) a Silicon Valley tech company that makes high performance data switches used for campuses, cloud services and data centers. When Ed steps away from his management duties, you can often find him on the athletic fields cheering on his three children or cooking in the kitchen with family and friends.
President and CEO
Dave Monahan is President and CEO of FitLinxx (www.FitLinxx.com), a provider of health and wellness technology that motivates people to live actively and improve their well-being. With expertise in sales, marketing, and engineering, Dave has helped transform FitLinxx into an industry-leading provider of wireless activity, health and fitness devices. Prior to joining FitLinxx, Dave held senior management positions with Microsoft, SkyTel and Phillips International. Dave has a BS in Mechanical Engineering from Pennsylvania State University and an MBA in International Business from Loyola College.
Byron Osing, PhD
Dr. Byron Osing is the CEO/Chair, and primary driver behind the direction of Calgary Scientific Inc. Dr. Osing is the former President and Chief Executive Officer of Telebackup Systems Inc., he was one of three founding shareholders responsible for driving the company’s success, leading to an acquisition by the largest USA data storage management software company, Veritas Software, Inc. Dr. Osing was also previously co-founder and former CEO and Chair of 180 Connect, Inc., a publicly traded technical services organization that reached nearly 5,000 employees by the time it was acquired by DTV. Dr. Osing has a BA in Psychology from the University of Lethbridge, and an MBA and a PhD in Marketing and New Enterprise Development from the University of Calgary. He is a recipient of the Ernst & Young “Emerging Entrepreneur of the Year Award” for the Prairies Region and “Canada’s Top 40 Under 40 Award.”
Matt Patterson, MD
Dr. Matt Patterson has built his career around the goal of delivering better quality care to more people at a lower cost. Responsible for overall client facing operational activities, he leads AirStrip in shaping and informing the people, processes, and technology required to deliver the full value of AirStrip mobile solutions to clients. Dr. Patterson joined AirStrip from McKinsey & Company, where he was a core leader in the North American Healthcare practice’s strategy and operations engagements. He focused on clinical and business model transformations of major U.S. health systems transitioning from “pay for volume” to “pay for value” environments. Dr. Patterson also brings a wealth of clinical and operational leadership from his experience as a former U.S. Navy physician, where he served as the Medical Director of the Naval Special Warfare Center in San Diego, CA—the elite training command of the U.S. Navy SEALs.
CEO and Co-Founder
Jon Pearce is CEO and Co-Founder of Zipnosis. Jon co-founded Zipnosis in 2009 while working on his MBA at the Carlson School of Management. Prior to business school, Jon was a product manager at ProVation Medical, a healthcare software startup that was acquired by Wolters Kluwer in 2006. Jon has a B.A. in Russian Language with a Computer Science concentration from St. Olaf College. You can find him running, biking, and swimming around the Twin Cities or wandering around St. Paul with his wife and 2 year-old son.
Senior Vice President, Emerging Devices
Chris Penrose is Senior Vice President of AT&T’s Emerging Devices Organization. Chris leads a team that is responsible for connecting AT&T’s wireless network to devices in the automotive, mobile computing, mHealth and consumer electronics industries. With more than two decades of experience with AT&T and its predecessor companies, Penrose has expertise in strategic planning, new product development, sales, marketing, distribution planning and customer service. Prior to this role, Penrose was Vice President/General Manager of AT&T’s South Texas Market, where he had complete P&L responsibility for both wireline and wireless products. He held a similar position with AT&T in Virginia and West Virginia. Penrose earned a Bachelor in Science in Marketing and a Masters in Business Administration from Indiana University. He is active in the community, having served on the boards of directors of Junior Achievement, the University of Texas at San Antonio, the North Texas Chamber of Commerce and the San Antonio Sports Foundation.
Ramesh R. Rao, PhD
Director, UCSD Division of the California Institute for Telecommunications and Information Technology (Calit2) and Professor, Electrical and Computer Engineering, Jacobs School of Engineering, UCSD
Dr. Ramesh R. Rao is a faculty member at UC San Diego and the Director of the Qualcomm Institute, the UCSD division of the California Institute for Telecommunications and Information Technology (Calit2). He holds the Qualcomm Endowed Chair in Telecommunications and Information Technologies in the Jacobs School of Engineering at UCSD, is a member of the school’s Electrical and Computer Engineering department, and a founding member of UCSD’s new Center for Brain Activity Mapping (CBAM). Dr. Rao is an IEEE Fellow and Senior Fellow of the California Council on Science and Technology. Dr. Rao was named a member of various boards, including: the Rady Children’s Hospital and Health Center Board IT Task Force; the Board of Advisors at CommNexus San Diego; the UCSD Health System Advisory Board; and, the Health Authority of Abu Dhabi (HAAD) Weqaya Advisory Task Force in the United Arab Emirates. In his academic field, Dr. Rao has twice been elected to the IEEE Information Theory Society’s Board of Governors, was Publications Editor for IEEE Transactions on Information Theory, and Guest Editor for the IEEE Journal of Selected Areas in Communications. Dr. Rao earned his Bachelor’s degree from the University of Madras and his M.S. and Ph.D. in Electrical Engineering from the University of Maryland.
Zephyr Technology Corp
Brian Russell is the CEO and Founder of Zephyr Technology based in Annapolis, Maryland. Over the past two decades he has commercialized groundbreaking technology products. Zephyr is global leader in the area of wearable remote physiological monitoring solutions. ZephyrLIFE is a complete solution of wearable sensors and cloud based medical monitoring solution. Mr. Russell received his Bachelor of Engineering at Auckland University, New Zealand. He holds over 20 filed patents in the area optical communication, physiological sensing and wearable sensors. Brian.Russell@zephyranywhere.com
Valued Relationships, Inc
Andy Schoonover focuses on sales and business development activities, including MCOs, large partnerships and acquisition opportunities. Prior to joining VRI, Andy co-founded and was Managing Partner at Blue Canyon Capital, a private investment firm formed to make long term investments in profitable small and middle market companies. Andy joined VRI in 2007 after the Blue Canyon Capital’s recapitalization of VRI. Before Blue Canyon, Andy worked for Host Marriott Corporation (now Host Hotels & Resorts, NYSE: HST). At Host, Andy worked with the Treasury, Asset Management and Acquisition and Development groups and completed transactions valued at approximately $1.5 billion. Andy has also held positions with Florida Capital Partners and Blue Ridge Capital. Andy received his MBA from Stanford University and his BS from the McIntire School of Commerce at the University of Virginia, where he serves on the Schools Advisory Board.
Gad Shaanan is an entrepreneurial visionary and innovative designer who has dedicated his life to creating winning products and inventing new market opportunities. Born with a critical eye and deep curiosity as to how things work, Gad has launched and overseen the production of a myriad of products that millions of people use every day, with an emphasis on ease of use by having the device/service fit an individual’s daily life and not disrupt it. In doing so, he implements the value of a positive emotional connection between product, the consumer, and brand. Gad is the holder of numerous patents. He is a trusted advisor to Fortune 500 companies and a competitive strategist whose disciplines include marketing, product development, engineering, and design.
Chairman and CEO
Advanced ICU Care
Lou Silverman, Chairman and CEO of Advanced ICU Care, has served in executive leadership roles for healthcare technology and services companies for more than 20 years. Prior to joining Advanced ICU Care as Chairman and CEO, Silverman served for three years as CEO of Marina Medical Billing Services, Inc., a provider of revenue cycle management services to emergency department physicians. From 2000-2008, Silverman served as President and CEO of Quality Systems, Inc., an information technology company that develops and markets administrative and patient record software to hospitals, physicians and dentists. He is also the former Chief Operations Officer of CorVel Corp., a managed care services company serving the worker’s compensation, auto and health markets. Silverman earned his M.B.A. degree from the Harvard Business School and his B.A. degree in American Studies from Amherst College. He serves on the board of directors for a variety of healthcare companies, both public and private.
Mobilium Global Limited
Ralph Simon is acknowledged as one of the founders of the modern mobile entertainment industry. Over the last 15 years, he has been a prominent global mobile trailblazer and innovator, helping grow the mobile entertainment and content industry, and playing a central role in its impact and presence worldwide. Simon heads the London-based Mobilium International, which provides high-level strategic advice and guidance to mobile handset makers, telco operators, technology companies, media companies, movie studio & TV networks, global music artists, ad agency groups, brands, and platform providers around the world. In late 2013, Mobilium Africa launched the first comprehensive, pan-African and Africa-specific mobile health delivery network known as Smart Health Hub. Mobilium Africa has licensed the innovative Smart Health Hub health and wellness platform to Samsung, one of the world’s largest mobile device manufacturing companies. The Global Fund for AIDS, TB and Malaria is an official participant in Smart Health Hub, as is SafePoint Single-Use Syringes, and it also has the support of the World Health Organisation (WHO). Smart Health Hub is part of a wider range of mobile commerce, software and innovation that Mobilium has begun to bring to the entire African continent and rest of the world.
R. Jamie Spriggs
Jamie is the Chief Executive Officer and founder of ConnectYourCare. He has more than 20 years of leadership and senior management experience in insurance and benefits administration. His specific expertise is information technology, sales and operations. He is an expert in consumer-directed healthcare (CDH) technology, as well as the challenges and success stories of companies that have achieved significant cost savings through CDH. Jamie founded ConnectYourCare to focus exclusively on CDH and be the first company to combine health savings accounts and healthcare decision support tools into a coherent easy to understand and easy to implement platform. His extensive professional and sportsmanship background allows him to measure success on the micro level ensuring macro success. Prior to founding ConnectYourCare, Jamie founded RealLifeHR, a benefits industry start up that was subsequently acquired by a Fortune 500 company. Jamie was named an Ernst & Young Entrepreneur of the Year® 2012 award finalist. He has been recognized by the Wall Street Journal, CIO Magazine, HR Magazine, Cisco/Inc. Magazine and PC Computing Magazine for his contributions to the benefits and technology industries.
Steven R. Steinhubl, MD
Director of Digital Medicine, Scripps Translational Science Institute
Clinical Cardiologist, Scripps Health
DR. STEINHUBL is the Director of Digital Medicine at the Scripps Translational Science Institute and a clinical cardiologist at Scripps Health. He received his undergraduate training in engineering at Purdue University, graduate training in physiology at Georgetown University, and his medical degree at St. Louis University. Steve’s residency training was completed at David Grant USAF Medical Center and his cardiology fellowship at the Cleveland Clinic. Prior to joining Scripps, Steve was the Director of Cardiovascular Wellness and the Medical Director for Employee Wellness for the Geisinger Healthcare System. As a clinician-scientist, Dr. Steinhubl’s research activities have focused on clinical trials of novel therapeutic interventions to improve outcomes, ranging from the study of novel antithrombotic therapies to the application of an integrated systems-based approach for the optimal identification, communication and treatment of individual risk. He has been principal investigator or helped lead over a dozen large-scale, international randomized trials and has authored nearly 200 peer-reviewed manuscripts as well as numerous book chapters, and abstracts. At Scripps, through the development and oversight of a portfolio of clinical trials, Steve is responsible for helping develop the evidence base necessary to establish the role of mobile health technologies in the transformation of healthcare.
Senior Director, Product Development, Innovation Lead
Komathi Stem is a Global Innovation Business Leader at Genentech, a member of the Roche Group exploring how emerging technologies can transform drug development. She is a Biomedical Engineer with over 20 years of broad Pharma/Biotech industry experience ranging from Sales, Medical Affairs and Clinical Operations. She has built and lead field teams (Sales, Medical Liaisons, Regional Monitors) as well as Global Study Management and Data Management functions across multiple headquarter sites. Komathi graduated from St. Olaf College in Minnesota with a B.A. in Mathematics and received her M.S. in Biomedical Engineering from the University of Virginia in Charlottesville.
Epstein Becker Green
Bradley Merrill Thompson is a Member of the Firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory, reimbursement, and clinical trial issues. At the firm, Mr. Thompson leads the Medical Device Regulatory Practice, the Clinical Trials Initiative, and the Connected Health Initiative, and he serves on the firm’s National Health Care and Life Sciences Steering Committee. Mr. Thompson regularly defends companies receiving FDA warning letters, on a wide gambit of subjects including good manufacturing practice compliance and off label promotion. He frequently counsels companies on premarket clearance and approval strategies and on marketing strategies. When medical device companies become concerned that perhaps their employees have not followed FDA requirements, they often engage Mr. Thompson to investigate. With a special focus on drug delivery companies, Mr. Thompson also advises such companies on the unique aspects of combination product development and manufacturing. Education: J.D., cum laude, University of Michigan Law School, 1986; M.B.A., University of Illinois, 1983; B.A., cum laude, University of Illinois, 1982.
Vice President & General Manager
Rick is vice president of Qualcomm and the founder and general manager of Qualcomm Life, a wholly owned subsidiary of Qualcomm Incorporated. He is responsible for day-to-day operations as well as leading the company’s product development and technology strategy in the wireless health market. In addition to running Qualcomm Life, Rick oversees all corporate initiatives that drive innovation in wireless health at Qualcomm, including the strategic partnership with Rock Health and the $100 million Qualcomm Life Fund. As an advisor to Telcare, Inc., an early-stage health care device manufacturer, Rick helped the company launch the first cellular enabled diabetes blood glucose meter. Rick is currently an active member of HIMSS and mHIMSS. Previously, Rick founded and served as Chief Executive Officer and Chairman of the Board of ProfitLine, a business he built up from a one-man show into a $35 million enterprise, with 200 team members and 70 Fortune 1000 clients. Following this experience, Rick brought his technology expertise and entrepreneurial spirit to HCL Expense Management Services Inc., a $50 million subsidiary of HCL Technologies, as Chief Executive Officer.
Rick earned a bachelor’s degree in business administration and finance from California State University Northridge.
Tom Watlington, whose experience in the medical device industry spans 28 years, joined Sotera Wireless as Chief Executive Officer in February 2006. During that year he served a dual role as President of Naviscan Pet Systems, a medical imaging company, before transitioning to a full-time position with Sotera Wireless in January 2007.For ten years prior to joining Sotera Wireless, Mr. Watlington served as Senior Vice President of Commercial Operations and later as Executive Vice President and Chief Operating Officer of Biosite Incorporated, a leader in the field of medical diagnostics. In addition, he spent fourteen years at Boehringer Mannheim Corporation in various sales, marketing and strategic roles, including Vice President of Marketing for the Diabetes Care division. Mr. Watlington previously served on the board of Home Diagnostics, Inc., a public company in the field of diabetes monitoring that was acquired in June 2010 by Nipro Diagnostics. He received a bachelor of science degree from the University of Maryland.
Michael K. Wons
CellTrak Technologies, Inc.
Michael K. Wons is an experienced senior executive who is leading all aspects of CellTrak’s strategy and execution of its business plan. With more than 25 years of experience with leading healthcare and advanced technology companies, Mr. Wons brings a unique “customer focused” perspective to lead CellTrak where he is focused on rapid expansion of the business across the globe, product additions and build-out, intellectual property protection, and capital and investor fund raising. Mike is a passionate leader experienced with engaging customers, partners and the industry in the build out of mission critical solutions. Mr. Wons is also the Chairman of the Board at CellTrak and actively serves and participates in the National Association of Homecare and Hospice (NAHC) and the National Hospice and Palliative Care Organization (NHPCO). Mr. Wons also serves or has served in advisory board roles for Home Care & Hospice Strategic Planning Congress, Healthcare and Capital (HCap) Advisory Board, Electronic Visit Verification (EVV) work group, AT&T Field Services Advisory Board, Microsoft CTO Council and the Service Oriented Architecture Consortium (SOA-C). Mike is focused on helping establish a common platform for the industry to help enable automation of processes and improving the delivery of care via mHealth solutions.
Sr. Manager Government and Regulatory Affairs
Stephanie Zaremba is Senior Manager of Government and Regulatory Affairs at athenahealth, Inc., headquartered in Watertown, Massachusetts. athenahealth is a health information technology company that provides web-based electronic health record, care coordination, revenue cycle management, and patient communication services to physician groups. Ms. Zaremba manages athenahealth’s public policy initiatives, which are aimed at ensuring that federal policies enable innovation in health IT. She focuses on issues regarding patient safety, regulatory oversight of health IT, care coordination, and payment reform. She also represents athenahealth in a variety of health care and regulatory compliance issues, including in the design of athenahealth’s patient safety reporting program and partnership with Quantros PSO. Prior to joining athenahealth, Ms. Zaremba received her law degree from Boston College Law School. She graduated from Syracuse University with a degree in Policy Studies and Economics.